发力全球生物经济！美国领先企业发起美国生物制造联盟

Core Viewpoint - The establishment of the American Bio-Manufacturing Alliance (AAB) aims to enhance the U.S. bio-manufacturing capabilities, promote domestic innovation, and increase the country's influence in the rapidly growing global bio-economy [1][2] Group 1: Alliance Formation - The AAB was formed on May 21, 2023, and includes stakeholders from the bio-manufacturing sector, such as CEOs from Manus, Pivot Bio, Novonesis North America, Kula Bio, and LanzaTech Global [1] - The formation of the alliance follows a call from the emerging biotechnology national security council (NSCEB) for a coordinated national strategy to strengthen U.S. leadership in the field [1] Group 2: Objectives of AAB - AAB has two main objectives: to increase demand for bio-based products and technologies in the U.S. and to ensure a comprehensive market for existing and emerging bio-products [2] - Founding members highlighted the economic and environmental potential of bio-manufacturing, emphasizing the development of low-cost, high-performance agricultural inputs to reduce reliance on global supply chains [2] Group 3: Industry Impact - Bio-manufacturing is applicable across various sectors, including agriculture, energy, chemicals, materials, nutrition, and pharmaceuticals, utilizing biological materials to produce sustainable products [1] - The global bio-manufacturing market is currently valued at $20 billion and is expected to experience significant growth over the next decade [1]